Sales Alterar Data
Alnylam Pharmaceuticals USD 439.72M 310.81M 2023-12
BioCryst Pharmaceuticals USD 93.4M 6.66M 2023-12
Chugai Pharma JPY 273.81B 15.92B 2023-12
Daiichi Sankyo JPY 446.92B 71.42B 2023-12
DBV Technologies USD 2.18M 68K 2023-09
Enanta Pharmaceuticals USD 18M 929K 2023-12
Gilead Sciences USD 7.12B 64M 2023-12
GlaxoSmithKline GBP 8.05B 95M 2023-12
Glaxosmithkline GBP 8.05B 95M 2023-12
Incyte USD 1.01B 94.32M 2023-12
Intra Cellular Therapies USD 132.1M 5.93M 2023-12
Ionis Pharmaceuticals USD 325M 180.79M 2023-12
Karyopharm Therapeutics USD 33.75M 2.26M 2023-12
Neurocrine Biosciences USD 515.2M 16.4M 2023-12
Novavax USD 291.34M 104.36M 2023-12
PTC Therapeutics USD 307.06M 110.48M 2023-12
Regeneron Pharmaceuticals USD 3.43B 71.6M 2023-12
Roche Holding CHF 28.94B 842M 2023-12
Sarepta Therapeutics USD 396.78M 64.96M 2023-12
Ultragenyx Pharmaceutical USD 127.39M 29.34M 2023-12
Vertex Pharmaceuticals USD 2.52B 34.2M 2023-12



BioCryst Pharmaceuticals Vendas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2024.